15:16 , Mar 30, 2018 |  BC Week In Review  |  Clinical News

Allecra reports Phase II data for AAI101 combo to treat cUTI

Allecra Therapeutics GmbH (Lörrach, Germany) reported top-line data from the Phase II CACTUS trial in 45 hospitalized adults with complicated urinary tract infections (cUTIs), including pyelonephritis, showing that AAI101 in combination with cefepime was well...
01:20 , Jun 16, 2016 |  BC Extra  |  Financial News

Antibiotic play Allecra raises EUR 22M

Allecra Therapeutics GmbH (Lorrach, Germany) raised EUR 22 million ($24.8 million) in an untranched series B round led by new investor Delos Capital. Existing investors Forbion Capital Partners, Edmond de Rothschild Investment Partners, EMBL Ventures...